VSVlad Valentin Simianu

Vlad Valentin Simianu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Vlad Valentin Simianu has a total of 135 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Patient Perspectives on Barriers and Facilitators to 1-year Surveillance Colonoscopy Completion in Survivors of Colorectal Cancer: A Multimethod Analysis

    by Pranusha Atuluru, C. Natasha Kwendakwema, Ari M. Bell-Brown, Talor Hopkins, Vlad V. Simianu, Veena Shankaran, Rachel B. Issaka

    BACKGROUND: Patients treated for stage I to III colorectal cancer are at high risk for developing new and recurrent colon cancers. Therefore, professional organizations recommend a surveillance colonoscopy approximately 1-year postsurgical resection to ensure early detection. Despite these guidelines, surveillance colonoscopy completion rates remain suboptimal. OBJECTIVE: This multimethods study aimed to explore patient-identified barriers and facilitators affecting the completion of 1-year surveillance colonoscopies among stage I to III colorectal cancer survivors. DESIGN: Multimethods study. SETTINGS: The study was conducted within the Hutchinson Institute for Cancer Outcomes Research Value in Cancer Care Network, which comprises 46 clinics across 13 counties in Washington State. PATIENTS: We enrolled stage I to III colorectal cancer survivors who had not completed surveillance colonoscopy within 18 months of surgery. Participants completed questionnaires and semistructured interviews between December 2023 and June 2024. MAIN OUTCOME MEASURES: Questionnaire data and interview transcripts were independently coded and analyzed by 2 coders to identify key themes and subthemes related to barriers and facilitators of surveillance colonoscopy completion. RESULTS: The study included 19 patients. The median (interquartile range) participant age was 73 (17.8) years, 9 (47.4%) were men, and 8 (42.1%) had stage I cancer. All participants reported cognitive and environmental factors as both barriers and facilitators to surveillance colonoscopy completion. The most reported barriers were fear of the colonoscopy results and cancer recurrence (cognitive) and challenges with the bowel preparation (environmental). The most frequently reported facilitators were patient’s motivation to receive reassurance (cognitive) and clinic assistance in scheduling appointments (environmental). LIMITATIONS: Results may not be generalizable due to population and selection bias of participants. CONCLUSIONS: This study identified barriers and facilitators to completing a 1-year surveillance colonoscopy, which will guide future interventions. Addressing both psychological concerns and improving communication between patients and clinics could be key strategies to enhance adherence rates and improve long-term outcomes for colorectal cancer survivors. See Video Abstract . PERSPECTIVAS DE LOS PACIENTES SOBRE LAS BARRERAS Y LOS FACILITADORES PARA COMPLETAR LA COLONOSCOPIA DE SEGUIMIENTO AL AÑO EN SUPERVIVIENTES DE CÁNCER COLORRECTAL: UN ANÁLISIS MULTIMÉTODO: ANTECEDENTES: Los pacientes tratados por cáncer colorrectal en estadio I-III corren un alto riesgo de desarrollar nuevos cánceres de colon y de que estos reaparezcan. Por lo tanto, las organizaciones profesionales recomiendan una colonoscopia de vigilancia aproximadamente un año después de la resección quirúrgica para garantizar la detección precoz. A pesar de estas directrices, las tasas de realización de colonoscopias de vigilancia siguen siendo insuficientes. OBJETIVO: Este estudio multimétodo tenía como objetivo explorar las barreras y los facilitadores identificados por los pacientes que afectan a la realización de colonoscopias de vigilancia al año entre los supervivientes de cáncer colorrectal en estadio I-III. DISEÑO: Estudio multimétodo. ENTORNO: El estudio se llevó a cabo en el Hutchinson Institute for Cancer Outcomes Research Value in Cancer Care Network, que comprende 46 clínicas en 13 condados del estado de Washington. PACIENTES: Se inscribieron supervivientes de cáncer colorrectal en estadio I-III que no habían completado la colonoscopia de vigilancia en los 18 meses posteriores a la cirugía. Los participantes completaron cuestionarios y entrevistas semiestructuradas entre diciembre de 2023 y junio de 2024. PRINCIPALES MEDIDAS DE RESULTADOS: Los datos de los cuestionarios y las transcripciones de las entrevistas fueron codificados y analizados de forma independiente por dos codificadores para identificar los temas y subtemas clave relacionados con las barreras y los facilitadores de la realización de la colonoscopia de vigilancia. RESULTADOS: El estudio incluyó a diecinueve pacientes. La mediana (rango intercuartílico) de la edad de los participantes fue de 73 (17,8) años, 9 (47,4 %) eran hombres y 8 (42,1 %) tenían cáncer en estadio I. Todos los participantes informaron de factores cognitivos y ambientales como barreras o facilitadores para completar la colonoscopia de vigilancia. Las barreras más mencionadas fueron el miedo a los resultados de la colonoscopia y a la recurrencia del cáncer (cognitivo) y las dificultades con la preparación intestinal (ambiental). Los facilitadores más frecuentes fueron la motivación del paciente para recibir tranquilidad (cognitivo) y la ayuda de la clínica para programar las citas (ambiental). LIMITACIONES: Los resultados pueden no ser generalizables debido al sesgo de selección de la población y de los participantes. CONCLUSIONES: Este estudio identificó barreras y facilitadores para completar una colonoscopia de vigilancia anual con el fin de orientar futuras intervenciones. Abordar las preocupaciones psicológicas y mejorar la comunicación entre los pacientes y las clínicas podrían ser estrategias clave para mejorar las tasas de adherencia y los resultados a largo plazo de los supervivientes de cáncer colorrectal. ( AI-generated translation )

  • Open Access

    Results of a phase II trial of short-course radiation and TASOX [trifluridine/tipiracil (TAS-102) plus oxaliplatin] chemotherapy in operable rectal cancer

    by H.F. Kennecke, J.A. Zell, H. Pham, V.V. Simianu, K. Herz, A. Kelley, J.C. Carmichael, H. Hochster, L.A. Kachnic


  • Open Access

    Challenges and Opportunities for Colorectal Cancer Prevention in Young Patients

    by Hyung Kim, Anna Melio, Vlad Simianu, Gautam Mankaney

    There has been a well-documented increase in the incidence of colorectal cancer in patients under 50 years of age. Additionally, these patients present with later-stage cancer at diagnosis compared to their over-50 counterparts. However, there is limited consensus on how the impact of this evolving epidemiology should impact existing prevention and screening tools. Recently proposed strategies include increased genetic testing, improved young patient awareness through targeted media campaigns, and initiatives to increase clinical suspicion in primary care providers. Prevention is further complicated by nuances of treating colorectal cancer in the younger population, with underexplored concerns regarding fertility, sexual health, financial impact, and extended post-treatment surveillance. This review aims to summarize the changing epidemiology of colorectal cancer in young patients, overview existing screening guidelines, and discuss challenges and opportunities surrounding prevention of early-onset colon cancer.


  • Open Access

    “Impact of regional data reporting and feedback on rectal cancer surgery quality metrics in the Surgical Care Outcomes Assessment Program (SCOAP)”

    by Alex J. Charboneau, Chad Cragle, Joseph Frankhouse, Shalini Kanneganti, Jenny A. Kaplan, Ravi Moonka, Laila Rashidi, Vlad V. Simianu


  • Contemporary Colon Cancer Care

    by Vlad Valentin Simianu

    Caring for colon cancer is a fundamental pillar of colorectal surgery. The prevalence of colon cancer is rising in the population and this mainstay of our practice is becoming increasingly complex—with evolving technology, understanding of cancer biology, and improving cancer care delivery. This edition of Clinics in Colon and Rectal Surgery (CCRS) is intended to update on contemporary colon cancer care. We aim to provide a primer on some of the technical aspects of colon cancer operations, decision-making in particular clinical scenarios, nuances in individualizing perioperative care, and some of the evolving “big issues” that impact colon cancer care delivery. The edition begins with an excellent summary of the details that go in operative planning for oncologic colectomy. I am grateful to Drs. Bauer, Wlodarczyk, and Widmar for providing a thorough description of the concept and data behind complete mesocolic excision, and when to extend lymphadenectomy. This is followed by a discussion by Drs. Westfal and Curran of the journey to the wide adoption of minimally invasive surgery for colon cancer operations, and the future directions in which the field is expected to continue to evolve. The next sections dive into important decisions on patient selection. Drs. Hendren and Sommovilla review emerging data in patients with Lynch's syndrome—including how to selectively avoid extended resection based on pathogenic variants, patient-specific factors, and prevention strategies. Drs. Charboneau and Kaplan discuss endoscopic techniques and when to exercise caution with malignant polyps. Drs. Onyiego and Maykel review both operative and nonoperative options in managing and palliating malignant bowel obstructions. Across these articles, you will note summaries of current guidelines and also the multiple considerations for what might be the “right outcome” in these specific patients. The next two articles dive into important perioperative care related to colon cancer biology. Drs. Heit and Cohen provide a summary of current uses and limitations of contemporary circulating tumor DNA (ctDNA) assays, as well as a sneak peek of upcoming trials that will help guide clinical decision-making. Then, Drs. Pang, Baldi, and Herzig deliver a practical look at the data behind neoadjuvant chemotherapy and immunotherapy, and a guide on how to individualize postoperative therapy. This edition finishes with three important aspects of colon cancer care. Drs. Sokas and Ivantury introduce the use of patient-reported outcome measures (PROMs) in routine practice. This piece, I believe, offers important information that can enhance shared decision-making beyond traditional outcomes, and highlights special populations on which to focus these practices. Next, Drs. Shaefer and Harbaugh offer a thought-provoking piece on the good and bad of centralizing colon cancer care. Finally, Drs. Morris and Kin use the perspectives of appropriateness and standards of care to elaborate on how to continue to elevate high-quality colon cancer care. I am grateful for the time and expertise of the many authors who contributed to this edition. They are leaders in the field of colon cancer, and I believe you will find new and practical information in each article. Continuing to be engaged and meticulous in colon cancer care—from patient selection to technical aspects of our operations to building successful health systems—is critical to elevating the care we deliver to our patients. Article published online: 13 January 2025 © 2025. Thieme. All rights reserved. Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

  • Open Access

    The conundrum of the giant condyloma: is it carcinoma?

    by Hyung C Kim, James D Schlenker, Amber B Post, Nicholas S Agoff, Timothy Feldmann, Vlad V Simianu

    Perineal verrucous carcinoma is a rare variant of squamous cell carcinoma that is mainly treated with surgical excision. In this case report, we present a 58-year-old man with human immunodeficiency virus who presented with an extraordinarily large perineal mass that was ultimately found to be verrucous carcinoma in association with giant condyloma acuminata. He was treated with a wide local excision followed by staged abdominoperineal resection and fasciocutaneous flap reconstruction. In the post-operative course, the patient developed relatively short interval recurrence which was successfully managed with salvage radiotherapy. He is now post-radiation without evidence of recurrence.


  • Expert Review on Neoadjuvant Therapy for Colon Cancer

    by Vlad V. Simianu

    An abstract is unavailable. This article is available as a PDF only.

  • Open Access

    Contemporary management of anorectal fistula

    by Hyung Chan Kim, Vlad V. Simianu


  • Characterizing Regionalization of Inflammatory Bowel Disease Hospitalizations and Operations in Washington State

    by Stephanie L. Stovall, Celine R. Soriano, Jennifer A. Kaplan, Danielle La Selva, James Lord, Ravi Moonka, Timothy L. Zisman, Vlad V. Simianu